Autoimmune Congenital Complete Heart Block: How Late Can It Occur?
- PMID: 37168107
- PMCID: PMC10166639
- DOI: 10.1055/s-0043-1768708
Autoimmune Congenital Complete Heart Block: How Late Can It Occur?
Abstract
Objective Maternal anti-Ro (SSA) and/or anti-La (SSB) antibodies are a risk factor for congenital complete heart block (CHB). Because detailed analysis of the incidence of CHB after 24 weeks of gestational age (GA) is lacking, we aimed to ascertain the risk of "later-onset" CHB among offspring of SSA/SSB-positive mothers in the published literature. Study Design Using search terms "neonatal lupus heart block" and "autoimmune congenital heart block" on PubMed and Ovid, we gathered prospective studies of SSA/SSB-positive mothers with fetal echo surveillance starting from before CHB diagnosis and retrospective cases of fetal CHB diagnosis after 24 weeks of GA (if there was prior normal heart rate) or after birth. Results Ten prospective studies included 1,248 SSA/SSB-positive pregnancies with 24 cases of CHB diagnosed during pregnancy (1.9%). Among these, three (12.5%) were after 24 weeks-at weeks 25, 26, and 28. Our retrospective studies revealed 50 patients with CHB diagnosis in late fetal life and neonatal period and 34 in the nonneonatal childhood period. An additional four cases were diagnosed after age 18 years. Conclusion Later-onset autoimmune CHB in offspring of SSA/SSB-positive mothers does occur. Our analysis suggests that prenatal surveillance should continue beyond 24 weeks of GA but is limited by inconsistent published surveillance data.
Keywords: complete heart block; congenital heart block; fetal echocardiography; neonatal lupus.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).
Conflict of interest statement
Conflict of Interest None declared.
Similar articles
-
[Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].Pathol Biol (Paris). 2004 Apr;52(3):138-47. doi: 10.1016/j.patbio.2003.06.002. Pathol Biol (Paris). 2004. PMID: 15063933 Review. French.
-
Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.Immunol Res. 2017 Apr;65(2):487-494. doi: 10.1007/s12026-016-8888-5. Immunol Res. 2017. PMID: 28138914
-
Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.Autoimmun Rev. 2013 Sep;12(11):1039-45. doi: 10.1016/j.autrev.2013.04.006. Epub 2013 May 15. Autoimmun Rev. 2013. PMID: 23684701 Review.
-
Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry.J Am Coll Cardiol. 1998 Jun;31(7):1658-66. doi: 10.1016/s0735-1097(98)00161-2. J Am Coll Cardiol. 1998. PMID: 9626848
-
Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.J Rheumatol. 1996 May;23(5):925-32. J Rheumatol. 1996. PMID: 8724310
Cited by
-
Molecular Mechanisms of Fetal and Neonatal Lupus: A Narrative Review of an Autoimmune Disease Transferal across the Placenta.Int J Mol Sci. 2024 May 10;25(10):5224. doi: 10.3390/ijms25105224. Int J Mol Sci. 2024. PMID: 38791261 Free PMC article. Review.
-
Prospective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies.Arthritis Rheumatol. 2024 Mar;76(3):411-420. doi: 10.1002/art.42733. Epub 2023 Nov 10. Arthritis Rheumatol. 2024. PMID: 37947364
References
-
- Brucato A, Frassi M, Franceschini F. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum. 2001;44(08):1832–1835. - PubMed
-
- Gladman G, Silverman E D, Law Y. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies. Am J Perinatol. 2002;19(02):73–80. - PubMed
-
- Costedoat-Chalumeau N, Amoura Z, Lupoglazoff J M. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum. 2004;50(10):3187–3194. - PubMed
-
- PRIDE Investigators . Friedman D M, Kim M Y, Copel J A. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation. 2008;117(04):485–493. - PubMed
-
- Rein A J, Mevorach D, Perles Z. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study. Circulation. 2009;119(14):1867–1872. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials